← Back to Clinical Trials
Recruiting NCT07128446

NCT07128446 COPM-Based Goal Setting Strategies in the PICU

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07128446
Status Recruiting
Phase
Sponsor Samsung Medical Center
Condition Critical Illness
Study Type INTERVENTIONAL
Enrollment 5 participants
Start Date 2025-08-29
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Standard physical and occupational therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 5 participants in total. It began in 2025-08-29 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

COPM-Based Goal Setting Strategies in the PICU

Eligibility Criteria

Inclusion Criteria: Phase 1-2 (Delphi Survey - Experts) * Physicians specializing in pediatrics or physical medicine and rehabilitation, occupational therapists, physical therapists, and nursing staff * Minimum of 2 years of direct clinical experience in a Pediatric Intensive Care Unit (PICU) Phase 3 (Pilot Testing - Caregivers \& PICU Clinicians) Caregivers: * Legal guardian of a child aged 1-18 years admitted to PICU * ≥24 hours post-admission PICU clinicians: \- Treating occupational or physical therapist involved in the child's care during PICU admission Exclusion Criteria: Phase 1-2 (Delphi Survey - Experts) * Rehabilitation professionals without prior PICU clinical experience * Inability to read or respond to Korean-language surveys Phase 3 (Pilot Testing - Caregivers \& PICU Clinicians) * Caregivers experiencing severe emotional distress, or deemed inappropriate for participation by the treating clinician * Non-Korean-speaking caregivers * Refusal or withdrawal of informed consent at any stage

Contact & Investigator

Central Contact

JEONG-YI KWON, MD, PHD

✉ jeongyi.kwon@samsung.com

📞 +821045911039

Frequently Asked Questions

Who can join the NCT07128446 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 18 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07128446 currently recruiting?

Yes, NCT07128446 is actively recruiting participants. Contact the research team at jeongyi.kwon@samsung.com for enrollment information.

Where is the NCT07128446 trial being conducted?

This trial is being conducted at Seoul, South Korea, Seoul, South Korea.

Who is sponsoring the NCT07128446 clinical trial?

NCT07128446 is sponsored by Samsung Medical Center. The trial plans to enroll 5 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology